Related Experiment Video
Updated: Jul 14, 2026
08:27
The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
Published on: July 25, 2011
Statins: multiple mechanisms of action in the ischemic brain
Mauro Cimino1, Paolo Gelosa, Anita Gianella
1Institute of Pharmacology and Pharmacognosy, University of Urbino Carlo Bo, Urbino, Italy.
Summary
Statins significantly reduce stroke incidence through pleiotropic, non-cholesterol effects. These mechanisms include enhanced nitric oxide bioavailability, antioxidant and anti-inflammatory actions, offering neuroprotection beyond lipid lowering.
Area of Science:
- Neuroscience
- Pharmacology
- Cardiovascular Research
Background:
- Epidemiological studies show no cholesterol-stroke link, yet statins reduce stroke incidence.
- Clinical trials highlight statins' efficacy in stroke prevention, suggesting non-cholesterol-dependent mechanisms.
Purpose of the Study:
- To elucidate the pleiotropic, neuroprotective mechanisms of statins in stroke models.
- To explore how statins offer protection independent of their cholesterol-lowering effects.
Main Methods:
- Review of animal models investigating statin's effects on stroke.
- Analysis of biochemical and cellular pathways affected by statin administration.
Main Results:
- Statins enhance nitric oxide bioavailability, improving cerebral perfusion and endothelial function.
- Statins exhibit antioxidant, anti-inflammatory, immunomodulatory, and progenitor cell-regulating effects.
- Inhibition of isoprenoid synthesis underlies many of statins' pleiotropic actions.
Conclusions:
- Statins provide neuroprotection against stroke through multiple mechanisms beyond cholesterol reduction.
- Understanding these pleiotropic effects is crucial for optimizing statin therapy in stroke prevention.
Related Concept Videos
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...